SCHEMBL17063602

SCHEMBL17063602

COC(=O)c1c(Cl)cc(Cl)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
KMT2A Q03164 5/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
ERN1 O75460 1/20 0.42
TP53 P04637 1/20 0.41
MDM2 Q00987 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 4/20 0.41
MEN1 O00255 3/20 0.40
HSD17B10 Q99714 2/20 0.40
ACLY P53396 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLCO1B3 Q9NPD5 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SLCO1B1 Q9Y6L6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26604916 0.90 GAA (0.47) GAAKMT2AMAPTERN1TP53
SCHEMBL5542753 0.86 KMT2A (0.53) GAAKMT2AMAPTLMNATP53
SCHEMBL3028435 0.83 KDM4E (0.47) KMT2AMAPTLMNAERN1KDM4E
SCHEMBL3233109 0.83 ERN1 (0.47) GAAKMT2AMAPTLMNAERN1
Hydrochloric Acid SCHEMBL10398546 0.81 KDM4E (0.46) KMT2AMAPTLMNAERN1KDM4E
SCHEMBL17351004 0.81 KDM4E (0.42) GAAKMT2AMAPTLMNAERN1
SCHEMBL31488017 0.80 GAA (0.43) GAAMAPTLMNAHTTHSD17B10
SCHEMBL1515888 0.80 KMT2A (0.46) GAAKMT2AMAPTKDM4EMEN1
SCHEMBL2021435 0.79 CYP3A4 (0.50) GAAKMT2AMAPTLMNAHTT
SCHEMBL3119398 0.79 CYP3A4 (0.50) GAAKMT2ALMNAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150250769-A1 METHODS AND COMPOSITIONS FOR INHIBITING RHO/MRTF-MEDIATED DISEASES AND CONDITIONS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2015-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150250769-A1 METHODS AND COMPOSITIONS FOR INHIBITING RHO/MRTF-MEDIATED DISEASES AND CONDITIONS RHOA, ARHGEF1, ARHGEF2 GAA 2428/4885KMT2A 2358/4885MAPT 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.